# glycopyrrolate

NDC: 71656-061
Generic name: glycopyrrolate
Labeler / Manufacturer: Saptalis Pharmaceuticals, LLC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20241125

FDA application: ANDA216297

## Active ingredients

- GLYCOPYRROLATE: 1 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71656-061"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71656-061
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e6f8091-d6fe-4c8f-b897-606a70bf74bc